The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India, China and other Emerging Markets. Our team supports the growth of the portfolio companies through all stages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
We seek to be a reliable and value-added financing partner for our companies. HBM Healthcare Investments, our main fund, invests in private and public companies as well as IPOs and is therefore ideally suited to support later-stage companies prior to a potential going public or trade sale.